Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah L Thompson

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cell Reports|October 18, 2018
The p38α Stress Kinase Suppresses Aneuploidy Tolerance by Inhibiting Hif-1αSusana Simões-Sousa, Samantha Littler, Sarah L Thompson, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Oncogene-like addiction to aneuploidy in human cancersVishruth Girish, Asad A Lakhani, Christine M Scaduto, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
A clinical-stage oncology compound selectively targets drug-resistant cancersKaitlin Long, Debanjan Bhattacharjee, Samuel H Newman-Stonebraker, et al.
Science (New York, N.Y.)|July 6, 2023
Oncogene-like addiction to aneuploidy in human cancersVishruth Girish, Asad A Lakhani, Sarah L Thompson, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
On-target toxicity limits the efficacy of CDK11 inhibition against cancers with 1p36 deletionsLinda Julian, Lisa Crozier, Devon Lukow, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cell Reports|October 18, 2018
The p38α Stress Kinase Suppresses Aneuploidy Tolerance by Inhibiting Hif-1αSusana Simões-Sousa, Samantha Littler, Sarah L Thompson, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Oncogene-like addiction to aneuploidy in human cancersVishruth Girish, Asad A Lakhani, Christine M Scaduto, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
A clinical-stage oncology compound selectively targets drug-resistant cancersKaitlin Long, Debanjan Bhattacharjee, Samuel H Newman-Stonebraker, et al.
Science (New York, N.Y.)|July 6, 2023
Oncogene-like addiction to aneuploidy in human cancersVishruth Girish, Asad A Lakhani, Sarah L Thompson, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
On-target toxicity limits the efficacy of CDK11 inhibition against cancers with 1p36 deletionsLinda Julian, Lisa Crozier, Devon Lukow, et al.
Pageof 3